♦Pumas: Pharmaceutical Modeling and Simulation software. One tool for all drug development data analysis needs.
♦Lyv: Data-driven Clinical Decision Support System. It leverages clinical research and Electronic Health Record data from millions of patients to derive algorithms to personalize healthcare delivery.
♦The experienced consulting team at Pumas-AI, Inc. offers PK, PKPD modeling & simulation during product development and for regulatory submissions.
Overview
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 2, 2026 | PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research to ACoP 2026 | PumasAI Pre-conference workshop on the future of AI in pharmacometrics and four scientific poster presentations highlight PumasAI’s presence at ACoP 2026 NATIONAL HARBOR, MD, UNITED STATES, October 2, 2026 /EINPresswire.com/ -- PumasAI, an ... |
| Aug 19, 2026 | PumasAI Launches New Clinical Pharmacology Webinar Series Showcasing End-to-End AI-Powered PK Analysis | PumasAI Four-part PumasCP End-to-End series shows clinical pharmacology teams how to go from raw data to regulatory-ready reporting in one reproducible environment DOVER, DE, UNITED STATES, August 19, 2026 /EINPresswire.com/ -- PumasAI, an ... |
| Jul 20, 2026 | PumasAI Helps Launch India's First Computational Lab for Quantitative Sciences to Advance AI in Drug Development | PumasAI New collaboration with PSGIMSR and SOPHAS strengthens education and infrastructure for the next generation of clinical pharmacology and pharmacometrics leaders. This laboratory represents an investment in future scientists, future d... |
| May 21, 2026 | PumasAI Launches Enterprise AI Transformation Service Proven to Help Pharmaceutical Teams Reach 50% Productivity Growth | New offering helps pharmaceutical and biotech organizations modernize pharmacometrics workflows, reduce manual work, and accelerate drug development timelines DOVER, DE, UNITED STATES, May 21, 2026 /EINPresswire.com/ -- PumasAI, an AI-power... |
| Apr 2, 2026 | Workshop on Quantitative Systems Pharmacology Workflows in Pumas™ Created by PumasAI for QSPC 2026 | PumasAI DOVER, DE, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- PumasAI, a science-first organization that turns data into life-saving decisions faster, today announced a major presence at the Quantitative Systems Pharmacology Confere... |
| Sep 7, 2021 | Pumas-AI looks to democratize access to drug development tools | For the cofounders of University of Maryland, Baltimore startup Pumas-AI, technology has the power to democratize access to advanced tools. The startup’s pharmaceutical modeling and simulation platform has two products, both aimed at provid... |
| Aug 12, 2020 | UMB-born startup launches pharmaceutical modeling platform Pumas 1.0 | A startup launched out by faculty at University of Maryland, Baltimore and MIT researchers collaborated to launch Pumas 1.0, a predictive analytics platform that aids in the development cycle of pharmaceutical drugs. What that means is Puma... |
Reviews 0
FAQ about Pumas-AI
When was Pumas-AI founded?
Pumas-AI was founded in 2019.
What has the press written about Pumas-AI?
Parsers VC has collected 8 articles mentioning Pumas-AI, among them “PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research to ACoP 2026” (Oct 2, 2026) and “PumasAI Launches New Clinical Pharmacology Webinar Series Showcasing End-to-End AI-Powered PK Analysis” (Aug 19, 2026).
Is Pumas-AI still active?
Yes, Pumas-AI is active; its latest activity on Parsers VC dates from Nov 6, 2026.